Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Re han"'
Autor:
Wang, Wei, Cui, Xi-Wei, Gu, Yi-Hui, Wei, Cheng-Jiang, Li, Yue-Hua, Ren, Jie-Yi, Chung, Man-Hon, Aimaier, Re-han-gu-li, Zhang, Hai-Bing, Li, Qing-Feng, Wang, Zhi-Chao
Publikováno v:
In Journal of Investigative Dermatology March 2022 142(3) Part A:613-623
Autor:
Jobie Budd, Benjamin S. Miller, Nicole E. Weckman, Dounia Cherkaoui, Da Huang, Alyssa Thomas Decruz, Noah Fongwen, Gyeo-Re Han, Marta Broto, Claudia S. Estcourt, Jo Gibbs, Deenan Pillay, Pam Sonnenberg, Robyn Meurant, Michael R. Thomas, Neil Keegan, Molly M. Stevens, Eleni Nastouli, Eric J. Topol, Anne M. Johnson, Maryam Shahmanesh, Aydogan Ozcan, James J. Collins, Marta Fernandez Suarez, Bill Rodriguez, Rosanna W. Peeling, Rachel A. McKendry
Publikováno v:
Nature Reviews Bioengineering. 1:13-31
Autor:
Artem Goncharov, Hyou‐Arm Joung, Rajesh Ghosh, Gyeo‐Re Han, Zachary S. Ballard, Quinn Maloney, Alexandra Bell, Chew Tin Zar Aung, Omai B. Garner, Dino Di Carlo, Aydogan Ozcan
We demonstrate multiplexed computational sensing with a point-of-care serodiagnosis assay to simultaneously quantify three biomarkers of acute cardiac injury. This point-of-care sensor includes a paper-based fluorescence vertical flow assay (fxVFA) p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::277e2b08c5c2c44cb2e5d95fb0740484
http://arxiv.org/abs/2301.10934
http://arxiv.org/abs/2301.10934
Autor:
Gyeo-Re Han, Min-Gon Kim
Publikováno v:
Sensors, Vol 20, Iss 9, p 2593 (2020)
Lateral flow assays (LFAs) have become the most common biosensing platforms for point-of-care testing due to their compliance with the ASSURED (affordable, sensitive, specific, user-friendly, rapid/robust, equipment-free, and deliverable to end-users
Externí odkaz:
https://doaj.org/article/c045440fe6694d6f9aa73760044cd562
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 9:1003-1010
Publikováno v:
Analytical Chemistry. 92:11530-11534
Diabetes mellitus is one of the most common chronic diseases worldwide. Generally, the levels of fasting or postprandial blood glucose and other biomarkers, such as glycated albumin, glycated hemoglobin, and 1,5-anhydroglucitol, are used to diagnose
Publikováno v:
ACS Applied Materials & Interfaces. 12:34564-34575
As a global shift continues to occur in high burden diseases toward developing countries, the importance of medical diagnostics based on point-of-care testing (POCT) is rapidly increasing. However, most diagnostic tests that meet clinical standards r
Publikováno v:
ACS Applied Materials & Interfaces. 12:1885-1894
Paper-based lateral flow assays (LFAs) are among the most widely used biosensing platforms for point-of-care testing (POCT). However, the conventional colloidal gold label of LFAs show low sensitivity and limited quantitative capacity. Alternatively,
Autor:
Min-Gon Kim, Gyeo-Re Han
Publikováno v:
Biotechnology and Bioprocess Engineering. 24:206-214
Design and synthesis of a conjugate with high specificity and sensitivity constitutes a fundamental process for developing a highly sensitive immunoassay. In this study, we investigated the process of design, synthesis, and evaluation of gold nanopar
Autor:
Min-Gon Kim, Gyeo-Re Han
Publikováno v:
Sensors (Basel, Switzerland)
Sensors, Vol 20, Iss 2593, p 2593 (2020)
Sensors
Volume 20
Issue 9
Sensors, Vol 20, Iss 2593, p 2593 (2020)
Sensors
Volume 20
Issue 9
Lateral flow assays (LFAs) have become the most common biosensing platforms for point-of-care testing due to their compliance with the ASSURED (affordable, sensitive, specific, user-friendly, rapid/robust, equipment-free, and deliverable to end-users